Skip to main content

Table 1 Participant characteristics at baseline survey by change in household income for women in the Young and Strong trial in 2012–2013

From: Prospective evaluation of the impact of stress, anxiety, and depression on household income among young women with early breast cancer from the Young and Strong trial

 

Change in Household Income

 

Maintain ≥ $100,000

(N = 132)

Same < $100,000

(N = 115)

Gained (N = 54)

Lost (N = 55)

 
 

N. (%)

N. (%)

N. (%)

N. (%)

p value

Demographics

Age

    

0.16

  < 35

18 (13.6)

30 (26.1)

13 (24.1)

15 (27.3)

 

 35–39

38 (28.8)

23 (20.0)

15 (27.8)

11 (20.0)

 

 40–45

76 (57.6)

62 (53.9)

26 (48.2)

29 (52.7)

 

Education

    

< 0.0001a

  ≤ High School

1 (0.8)

13 (11.3)

11 (20.4)

10 (18.2)

 

  ≥ Some College

131 (99.2)

102 (88.7)

43 (79.6)

45 (81.8)

 

Married

    

< 0.0001

 Yes

122 (92.4)

82 (71.3)

43 (79.6)

41 (74.6)

 

 No

10 (7.6)

33 (28.7)

11 (20.4)

14 (25.5)

 

Children

    

0.07

 Yes

107 (81.1)

78 (67.8)

36 (67.7)

40 (74.1)

 

 No

25 (18.9)

37 (32.2)

18 (33.3)

14 (25.9)

 

Race/Ethnicity

    

0.31

 Non-Hispanic, White

108 (81.8)

85 (74.6)

38 (70.4)

41 (74.6)

 

 Hispanic, Black, Other

24 (18.2)

29 (25.4)

16 (29.6)

14 (25.5)

 

Region

    

0.19

 Northeast

38 (28.8)

30 (26.1)

11 (20.4)

12 (21.8)

 

 South/Southeast

22 (16.7)

34 (29.6)

18 (33.3)

18 (32.7)

 

 Midwest

46 (34.9)

38 (33.0)

15 (27.8)

18 (32.7)

 

  West

26 (19.7)

13 (11.3)

10 (18.5)

7 (12.7)

 

Change in Employment

    

0.23a

 None-Employed

85 (68.0)

66 (62.3)

26 (54.2)

33 (63.5)

 

 None-Unemployed

20 (16.0)

20 (18.9)

11 (22.9)

15 (28.9)

 

 Lost

1 (0.8)

0 (0.0)

1 (2.1)

0 (0.0)

 

 Gained

19 (15.2)

20 (18.9)

10 (20.8)

4 (7.7)

 

Household Income

    

< 0.0001

  < $50,000

0 (0.0)

32 (27.8)

37 (68.5)

23 (41.8)

 

 $50,000–$99,999

0 (0.0)

83 (72.2)

17 (31.5)

21 (38.2)

 

  ≥ $100,000

132 (100.0)

0 (0.0)

0 (0.0)

11 (20.0)

 

Cancer

Stage

    

0.01

 I

62 (47.0)

39 (33.9)

12 (22.2)

14 (25.5)

 

 II

54 (40.9)

61 (53.0)

31 (57.4)

28 (50.9)

 

 III

16 (12.1)

15 (13.0)

11 (20.4)

13 (23.6)

 

Estrogen Receptor

    

0.19

 Positive

107 (81.1)

82 (71.3)

37 (68.5)

40 (72.7)

 

 Negative

25 (18.9)

33 (28.7)

17 (31.5)

15 (27.3)

 

Progesterone Receptor

    

0.39

 Positive

99 (75.0)

79 (68.7)

36 (66.7)

35 (63.6)

 

 Negative

33 (25.0)

36 (31.3)

18 (33.3)

20 (36.4)

 

HER2

    

0.91

 Positive

30 (23.1)

26 (22.8)

12 (22.2)

15 (27.3)

 

 Negative

100 (76.9)

88 (77.2)

42 (77.8)

40 (72.7)

 

Baseline Cancer Treatment

Chemotherapy

    

0.01

 Yes/Planned

96 (73.3)

97 (85.8)

48 (88.9)

48 (88.9)

 

 No

35 (26.7)

16 (14.2)

6 (11.1)

6 (11.1)

 

Radiation

    

0.05

 Yes/Planned

69 (61.6)

59 (64.8)

39 (83.0)

31 (72.1)

 

 No

43 (38.4)

32 (35.2)

8 (17.0)

12 (27.9)

 

Endocrine Therapy

    

0.53

 Yes/Planned

97 (78.9)

78 (72.2)

34 (69.4)

37 (74.0)

 

 No

26 (21.1)

30 (27.8)

15 (30.6)

13 (26.0)

 

Baseline Psychosocial Measures

Stress

    

0.15a

 Low

52 (40.3)

42 (37.8)

16 (30.2)

14 (26.4)

 

 Moderate

73 (56.6)

61 (55.0)

32 (60.4)

32 (60.4)

 

 High

4 (3.1)

8 (7.2)

5 (9.4)

7 (13.2)

 

Anxiety

    

0.73

 Normal

55 (42.0)

50 (43.9)

19 (35.9)

20 (37.7)

 

 Borderline

31 (23.7)

29 (25.4)

11 (20.8)

16 (30.2)

 

 Anxiety

45 (34.4)

35 (30.7)

23 (42.4)

17 (32.1)

 

Depression

    

0.03

 No

85 (68.6)

63 (58.3)

27 (54.0)

23 (46.0)

 

 Yes

39 (31.5)

45 (41.7)

23 (46.6)

27 (54.0)

 
  1. (a)Fisher’s exact test; N=Number; missing: 1 children, 1 race/ethnicity, 25 employment, 3 HER2, 4 chemotherapy, 63 radiation, 26 endocrine therapy, 10 stress, 5 anxiety, 24 depression; 100% had/planned surgery; p -values were calculated using chi-square tests or Fisher’s exact tests (when ≤5 women)
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us